Ibrahim A Hashim
Overview
Explore the profile of Ibrahim A Hashim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
515
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ishaq A, Hamidi O, Hashim I
J Appl Lab Med
. 2025 Jan;
PMID: 39878551
Background: Hyperaldosteronism involves complex, multidisciplinary management, including clinical testing, radiological exams, and adrenal venous sampling (AVS). This study assesses AVS outcomes at a large referral center, focusing on cannulation success,...
2.
Trull Y, Hashim I, Poornima I, Willis M
J Appl Lab Med
. 2024 Jul;
9(6):1078-1083.
PMID: 38958127
No abstract available.
3.
Joseph J, Hashim I
Lab Med
. 2024 May;
55(6):717-723.
PMID: 38809761
Background: Appropriate age- and sex-specific reference intervals for alkaline phosphatase (ALP) are essential to identify patients with hypophosphatasia (low ALP) and to avoid unnecessary ALP isoenzymes analysis (elevated ALP). This...
4.
Aaron R, Tian T, Fleming G, Sacks D, Januzzi Jr J, Facc M, et al.
J Diabetes Sci Technol
. 2024 Jan;
18(3):733-740.
PMID: 38292004
The Biomarkers for the Diagnosis of Heart Failure in Diabetes webinar was hosted by Diabetes Technology Society on September 20, 2023, with the objective to review current evidence and management...
5.
Yeung A, Huang J, Pandey A, Hashim I, Kerr D, Pop-Busui R, et al.
Prog Cardiovasc Dis
. 2023 May;
79:65-79.
PMID: 37178991
Diabetes Technology Society assembled a panel of clinician experts in diabetology, cardiology, clinical chemistry, nephrology, and primary care to review the current evidence on biomarker screening of people with diabetes...
6.
Osa-Andrews B, Sanchez M, Hashim I
Lab Med
. 2023 Jan;
54(4):424-428.
PMID: 36637228
Objective: The Choosing Wisely initiative recommended cessation of folate measurement, suggesting folate supplementation in macrocytic anemia. This study reviewed the need for continued blood folate testing at a large SafetyNet...
7.
Quynh N Nguyen K, Langevin R, McPhaul M, Hashim I
Clin Chim Acta
. 2020 Dec;
514:90-95.
PMID: 33359057
Background: Macroprolactin (macPRL) is considered to be solely a prolactin antibody complex. We examined macPRL heterogeneity in samples from thirteen patients suspected of macroprolactinemia. Methods: Polyethylene glycol (PEG) precipitation, gel...
8.
Tanak A, Muthukumar S, Hashim I, Prasad S
Sci Rep
. 2020 Nov;
10(1):18804.
PMID: 33139830
Measuring the Parathyroid hormone (PTH) levels assists in the investigation and management of patients with parathyroid disorders. Rapid PTH monitoring is a valid tool for accurate assessment intraoperatively. Rapid Electro-Analytical...
9.
Vigen R, Diercks D, Hashim I, Pandey A, Zhong L, Kutscher P, et al.
JAMA Netw Open
. 2020 Apr;
3(4):e203359.
PMID: 32320036
Importance: High-sensitivity cardiac troponin T (hs-cTnT) protocols for the evaluation of chest pain in the emergency department (ED) may reduce unnecessary resource use and overcrowding. Objective: To determine whether the...
10.
Vakili H, Germans S, Dong X, Kansagra A, Patel H, Muthukumar A, et al.
Diagnostics (Basel)
. 2020 Apr;
10(4).
PMID: 32295157
Background: Therapeutic humanized IgG1 kappa monoclonal antibody (t-mAb), daratumumab (DARA) is a Food and Drug Administration approved drug for the treatment of relapsed/refractory plasma cell myeloma (PCM). DARA appears on...